Institutions Buying MEI Pharma Ahead Of Topline Data Catalyst In Mid-March
February 25, 2015 at 13:44 PM EST
MEIP is expecting to release important Phase II topline data next month. We expect to see the stock price continue to increase up until that time. If positive as we expect, the stock should even rally further.
